Connor, Clark & Lunn Investment Management (CC&L)
WST icon

Connor, Clark & Lunn Investment Management (CC&L)’s West Pharmaceutical WST Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$248K Sell
988
-5,611
-85% -$1.4M ﹤0.01% 1447
2025
Q4 		$1.82M Buy
+6,599
New +$1.81M ﹤0.01% 944
2024
Q3 		– Sell
-12,304
Closed -$4.05M – 1671
2024
Q2 		$4.05M Sell
12,304
-6,061
-33% -$2.14M 0.02% 476
2024
Q1 		$7.27M Buy
18,365
+16,016
+682% +$5.92M 0.03% 357
2023
Q4 		$827K Sell
2,349
-10,545
-82% -$3.73M ﹤0.01% 913
2023
Q3 		$4.84M Sell
12,894
-36,410
-74% -$14.1M 0.03% 407
2023
Q2 		$18.9M Sell
49,304
-39,726
-45% -$14.2M 0.09% 160
2023
Q1 		$30.8M Buy
89,030
+26,733
+43% +$7.81M 0.17% 110
2022
Q4 		$14.7M Buy
62,297
+58,477
+1,531% +$13.9M 0.08% 178
2022
Q3 		$940K Sell
3,820
-3,440
-47% -$1.05M 0.01% 675
2022
Q2 		$2.19M Buy
7,260
+4,430
+157% +$1.44M 0.01% 453
2022
Q1 		$1.16M Buy
2,830
+1,311
+86% +$513K 0.01% 628
2021
Q4 		$712K Buy
+1,519
New +$654K ﹤0.01% 734
2021
Q2 		– Sell
-7,173
Closed -$2.02M – 1124
2021
Q1 		$2.02M Buy
+7,173
New +$2.05M 0.01% 558
2020
Q4 		– Sell
-4,029
Closed -$1.11M – 1060
2020
Q3 		$1.11M Buy
4,029
+1,068
+36% +$283K 0.01% 601
2020
Q2 		$673K Buy
+2,961
New +$582K ﹤0.01% 696

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s WST Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its West Pharmaceutical (WST) stake by 85% in Q1 2026, selling an estimated $1.4M and leaving 988 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #1447.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in WST in Q2 2020 and has held it in 16 quarters since. The position peaked at $30.8M in Q1 2023. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 988 shares of West Pharmaceutical worth $248K as of Q1 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 5,611 West Pharmaceutical shares in Q1 2026, an estimated $1.4M.
  • West Pharmaceutical made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #1447 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in West Pharmaceutical in Q2 2020 and has held it in 16 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s West Pharmaceutical position peaked at $30.8M in Q1 2023.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.